{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:55:26Z","timestamp":1791474926221,"version":"4.3.4"},"reference-count":0,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"am","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Lay Summary<\/jats:title>\n                  <jats:p>In this retrospective cohort analysis, weight-loss medications GLP-1 RA drugs (Glucagon-like receptor 1 receptor agonist) were compared with weight-loss surgery in people with obesity and IBD. Patients using GLP-1\u2019s had fewer blood clots, disease flares and surgeries, suggesting a safer, less invasive option.<\/jats:p>","DOI":"10.1093\/crocol\/otag027","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T11:31:59Z","timestamp":1776166319000},"source":"Crossref","is-referenced-by-count":2,"title":["Comparison of IBD-Related Outcomes in Patients with Obesity Treated with GLP-1 Receptor Agonists Versus Bariatric Surgery"],"prefix":"10.1093","author":[{"given":"M Housam","family":"Nanah","sequence":"first","affiliation":[{"name":"Institution: Cleveland Clinic Foundation Department: Internal Medicine, , Location: Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Institution: Cleveland Clinic Foundation Department: Digestive Disease Institute, , Location: Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham","family":"Wehbe","sequence":"additional","affiliation":[{"name":"Institution: Cleveland Clinic Foundation Department: Digestive Disease Institute, , Location: Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Regueiro","sequence":"additional","affiliation":[{"name":"Institution: Cleveland Clinic Foundation Department: Digestive Disease Institute, , Location: Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,16]]},"container-title":["Crohn's &amp; Colitis 360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/advance-article-pdf\/doi\/10.1093\/crocol\/otag027\/68098337\/otag027.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/advance-article-pdf\/doi\/10.1093\/crocol\/otag027\/68098337\/otag027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T04:37:40Z","timestamp":1776400660000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/advance-article\/doi\/10.1093\/crocol\/otag027\/8656849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1093\/crocol\/otag027","relation":{},"ISSN":["2631-827X"],"issn-type":[{"value":"2631-827X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"article-number":"otag027"}}